In Vitro Mutagenesis Protocols pp 203-213
Approaches for Using Animal Models to Identify Loci That Genetically Interact with Human Disease-Causing Point Mutations
The complexity of human illnesses often extends beyond a single mutation in one gene. Mutations at other loci may act synergistically to affect the penetrance and severity of the associated clinical manifestations. Discovering the additional loci that contribute to an illness is a challenging problem. Animal models for disease, based on engineered point mutations in a homologous gene, have proven invaluable to better understand the mechanism(s) which give(s) rise to the observed physiological effects. Importantly, these animals can also function as the basis for genetic modifier screens to discover other loci which contribute to an illness. This chapter discusses the theory, considerations, and methodology for performing genetic modifier screens in animal models for human disease.
Key wordsModifier screen Genetic interaction Model organism MYH9-related disorders
- 1.Kunishima S, Kojima T, Matsushita T, Tanaka T, Tsurusawa M, Furukawa Y, Nakamura Y, Okamura T, Amemiya N, Nakayama T, Kamiya T, Saito H (2001) Mutations in the NMMHC-A gene cause autosomal dominant macrothrombocytopenia with leukocyte inclusions (May-Hegglin anomaly/Sebastian syndrome). Blood 97(4):1147–1149PubMedCrossRefGoogle Scholar
- 3.Seri M, Pecci A, Di Bari F, Cusano R, Savino M, Panza E, Nigro A, Noris P, Gangarossa S, Rocca B, Gresele P, Bizzaro N, Malatesta P, Koivisto PA, Longo I, Musso R, Pecoraro C, Iolascon A, Magrini U, Rodriguez Soriano J, Renieri A, Ghiggeri GM, Ravazzolo R, Balduini CL, Savoia A (2003) MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. Medicine (Baltimore) 82(3):203–215Google Scholar